Usefulness of High-frequency QRS Analysis in the Evaluation of Patients With Chest Pain
Sponsored by Ori Galante
About this trial
Last updated 10 years ago
Study ID
Status
Type
Placebo
Accepting
Not accepting
Trial Timing
Ended 12 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Patients with chest pain, suspected to have ACS
- Duration of chest pain greater than 20 minutes
- Time from onset of chest pain less than 12h
- Signed an informed consent
Exclusion Criteria
- History of trauma or any other evident medical cause of chest pain
- Prior coronary artery bypass graft
- Pre-excitation syndrome (example WPW)
- Atrial Fibrillation or significant ventricular arrhythmia
- Bundle branch block, intraventricular conduction delay or
- QRS duration greater than 120 ms
- Implanted pacemaker or defibrillator
- Patients who received fibrinolytic therapy, glycoprotein IIb or IIIa inhibitors before the initial ECG recording